Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism Virus replication inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24N4OS |
InChIKeyBGKHXVPRHGHGII-UHFFFAOYSA-N |
CAS Registry2086235-39-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rhinovirus infection | Preclinical | KR | 01 May 2022 |